Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BFRI - Biofrontera Inc. to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th 2023


BFRI - Biofrontera Inc. to Present at Third Annual Winter Wonderland - Best Ideas Virtual Investor Conference on February 21st - 24th 2023

WOBURN, MA / ACCESSWIRE / February 15, 2023 / Biofrontera, Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products has been invited to present at the Third Annual Winter Wonderland - Best Ideas Virtual Investor conference, which is being held virtually on February 21st - 24th, 2023. Biofrontera, Inc. Chief Executive Officer, Erica Monaco, and Chief Financial Officer, Fred Leffler will represent the company at the conference.

Biofrontera, Inc. is scheduled to present on Tuesday, February 21, 2023 at 10:00AM ET. Management will be available for one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay at https://www.webcaster4.com/Webcast/Page/2952/47627

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.wright@issuerdirect.com.

Investors can register here.

About the MicroCap Rodeo Winter Wonderland Best Ideas Conference
The MicroCap Rodeo is back with its Third Annual Winter Wonderland Best Ideas Conference. This conference is a virtual conference that brings you the top 37 best ideas. Qualified institutional investors recommended each of the 37 companies represented as one of their best ideas. Those of you who attended the 2019 MicroCap Rodeo in Austin, Texas, know that we're focused on alpha.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.

Contacts:

Biofrontera Investor Relations
ir@bfinc.com

SOURCE: Biofrontera, Inc.



View source version on accesswire.com:
https://www.accesswire.com/739381/Biofrontera-Inc-to-Present-at-Third-Annual-Winter-Wonderland-Best-Ideas-Virtual-Investor-Conference-on-February-21st-24th-2023

Stock Information

Company Name: Biofrontera Inc.
Stock Symbol: BFRI
Market: NASDAQ
Website: biofrontera-us.com

Menu

BFRI BFRI Quote BFRI Short BFRI News BFRI Articles BFRI Message Board
Get BFRI Alerts

News, Short Squeeze, Breakout and More Instantly...